-
Study on the mechanism of the new anti-glioma chemotherapy drug ACT001
Time of Update: 2020-05-29
Platinum drugs such as cisplatin are chemotherapy drugs for glioblastoma (GBM), often used in combination with tamoxamine, carmostine, etc., but their resistance and side effects limit clinical applic
-
Localization of key medical isotope products significantly reduces cancer treatment costs
Time of Update: 2020-05-29
Recently, China Nuclear Group was informed that the first batch of domestically produced by china Nuclear Power Research and Design Institute of the first batch of domestic ally-89 nuclide official
-
ASCO 2020: Roche's TIGIT monoantireactorandaandta and PD-L1 monoantigen Tecentriq combine to extend survival in patients with non-small cell lung cancer
Time of Update: 2020-05-29
The 2020 ASCO Conference Summary shows that the TIGIT targeting antibody tiragolumab and Tecentriq combination can improve objective remission and no progression survival compared to the use of PD-
-
Nat Gene: "Mutation" cells compete with each other to help prevent cancer
Time of Update: 2020-05-29
Introduction: Clones are cell communities formed by the division of a single stem cell through normal cells Mutations in human tissue, pieced together by clones, naturally occur throughout the life
-
FDA approves first drug for RET gene mutation or fusion cancer -- Retevmo
Time of Update: 2020-05-29
U.S Food and Drug Administration approved Lilly's Retevinib for the treatment of tumors with mutations or fusions in three RET genes -- non-small cell lung cancer (NSCLC), thyroid myelin carcinoma
-
FDA grants ENHERTU breakthrough therapy for HER2-positive antibody drug conjugated to treat HER2-positive metastatic stomach cancer
Time of Update: 2020-05-29
First Sando co-op and Aslicon's targeted HER2 antibody drug conjugated enHERTU (FAM-trastuzumab deruxtecan-nxki) were awarded the FDA-awarded breakthrough therapy (BTD) for the treatment of patient
-
Preprint: Study from 25 countries: High coffee intake reduces stomach cancer risk
Time of Update: 2020-05-29
Introduction: Coffee is one of the second most popular beverages in the world, and it has antioxidant and anti-tumor properties Stomach cancer is the fifth most common tumor in history and the seco
-
NAT COMMUN: TGF-beta signal promotes the production of IL-22, which promotes the production of colon cancer
Time of Update: 2020-05-29
IL-22 has dual function in the tumor In the short term, il-22 is produced to protect cells from genetically toxic stress, while uncontrolled IL-22 promotes tumor growth; TGF-beta 1 promotes differ
-
Radiology: Using thorium MRI to assess the amount of glycozysolutions in tumors
Time of Update: 2020-05-29
Background tumor cells often have a high rate of aerobic glycolysis, which can provide a sugar decomposition product for the organisms needed for the rapid growth and proliferation of cells Exist
-
ASCO 2020: Teresa's efficacy in early and mid-term NSCLC will be announced
Time of Update: 2020-05-29
As a detailed result of NSCLC-assisted therapy in Phase 3 clinical trialADAURA the third generation of EGFR inhibitor Tagrisso has been used as a first-line therapy to demonstrate excellent e
-
Sci Adv: Chinese researchers have developed high-performance cancer vaccine using new microcapsules
Time of Update: 2020-05-29
Introduction: As a treatment method of immunotherapy, cancer vaccine due to the body's microenvironment and other adverse factors, can not play its maximum effectiveness, but because of the cancer
-
JCI: Danish scientists find new breast cancer gene in young women
Time of Update: 2020-05-29
Introduction: According to the latest data from the 2018 International Agency for Research on Cancer (IARC), breast cancer is the highest incidence of cancer in women worldwide at 24.2%, with 52.9%
-
Current and trends in targeted treatment of lung cancer - fine, joint, overcoming drug resistance and brain metastasis
Time of Update: 2020-05-29
In recent years, the targeted treatment of lung cancer has developed rapidly, and the first-line treatment options and drug-resistant treatment strategies for patients with EGFR mutation-positive
-
Radiology: Convolution-based neural network software can improve the detection rate of malignant tumors in chest
Time of Update: 2020-05-29
Background the additional benefits of detecting malignant lung tumor nodules in chest syllomas using deep convolutional neural network (DCNN) software are yet to be verified by multicenter studie
-
Brit J Cancer: Prognosis of preoperative and postoperative tumor markers in patients with stomach cancer
Time of Update: 2020-05-29
In clinical practice, cancer embryo antigen (CEA) and CA19-9 are the most commonly measured markers before and after gastric cancer (GC) surgery However, it is not clear whether preoperative or pos
-
BMJ: Effects of BODY Mass Index in Adolescence on Cardiovascular, Diabetes and Tumor Risk in Later Life
Time of Update: 2020-05-29
Researchers recently assessed the effect of body mass index in adolescence on the risk of developing later life researchers collected data from the British Biobank and four large-scale genome-wi
-
China's Rare Mutation Collaboration Group on Lung Cancer officially established to focus on "rare patients" in large cancer strains
Time of Update: 2020-05-29
On May 13, 2020, the China Lung Cancer Rare Mutation Collaboration Group was launched online, marking the official establishment of China's first collaboration group for rare mutations in lung canc
-
Cell Death Dis: RAGE Plays a Cancer-Promoting Role in Lung Cancer
Time of Update: 2020-05-29
RAGE (late glycoprotein end-product receptor) is a multi-body receptor that is a member of the immunoglobulin superfamily The study found that it was associated with physiological stability, develo
-
FDA approves Dartumumab subcutaneous preparation for treatment of multiple myeloma
Time of Update: 2020-05-29
The FDA recently approved Johnson and Johnson's Dartumab subcutaneous preparation to treat multiple myeloma in adults The treatment will be sold under the name Darzalex Faspro Darzalex Faspro can b
-
J Hepatol: Single-region sample evaluates the reliability of tumor immune microenvironments in hepatocellular carcinoma
Time of Update: 2020-05-29
Heterogeneity in tumors in patients with hepatocellular carcinoma (HCC) is often reported Therefore, the reliability of a single-region tumor sample to assess the tumor immune microenvironment is a
